Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. UBS has ...

PORTLAND, Ore. -- Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer ...

A high-level overview of Regeneron Pharmaceuticals, Inc. (REGN) stock. View (REGN) real-time stock price, chart, news, analysis, analyst reviews and more.

23andMe looked set to be acquired by biopharma group Regeneron after a $256 million takeover deal was agreed last month, but Wojcicki now says she wants to table a new offer backed by "a Fortune ...

Bambu Ventures plans to bid $10 million for 23andMe’s online health-care platform as the DNA testing firm seeks court approval to sell its assets to its cofounder and a nonprofit.